A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

Clinical trial NCT06581328 · RECRUITING

Trial details

NCT number: NCT06581328
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Ulcerative Colitis Crohn's Disease

Start date: 2025-03-27
Primary completion: 2027-10-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.